Table of Contents
Advances in Vascular Medicine
Volume 2014 (2014), Article ID 204390, 12 pages
http://dx.doi.org/10.1155/2014/204390
Review Article

Vascular Aging across the Menopause Transition in Healthy Women

Division of Geriatric Medicine, University of Colorado Denver, Building L15 Rm 8111, 12631 East 17th Avenue, P.O. Box 6511, Aurora, CO 80045, USA

Received 3 February 2014; Accepted 23 June 2014; Published 17 July 2014

Academic Editor: Shane A. Phillips

Copyright © 2014 Kerrie L. Moreau and Kerry L. Hildreth. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart disease and stroke statistics—2014 update: a report from the American heart association,” Circulation, vol. 129, no. 3, pp. e28–e292, 2014. View at Publisher · View at Google Scholar
  2. E. G. Lakatta and D. Levy, “Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease,” Circulation, vol. 107, no. 1, pp. 139–146, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. K. L. Moreau, K. L. Hildreth, A. L. Meditz, K. D. Deane, and W. M. Kohrt, “Endothelial function is impaired across the stages of the menopause transition in healthy women,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 12, pp. 4692–4700, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. K. M. Gavin, D. R. Seals, A. E. Silver, and K. L. Moreau, “Vascular endothelial estrogen receptor α is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women,” The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 9, pp. 3513–3520, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. K. L. Moreau, A. Meditz, K. D. Deane, and W. M. Kohrt, “Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women,” The American journal of physiology: Heart and circulatory physiology, vol. 302, no. 5, pp. H1211–1218, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. K. L. Hildreth, W. M. Kohrt, and K. L. Moreau, “Oxidative stress contributes to large elastic arterial stiffening across the stages of the menopausal transition,” Menopause, vol. 21, no. 6, pp. 624–632, 2014. View at Publisher · View at Google Scholar
  7. K. L. Moreau, A. J. Donato, D. R. Seals et al., “Arterial intima-media thickness: Site-specific associations with HRT and habitual exercise,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 283, no. 4, pp. H1409–H1417, 2002. View at Google Scholar · View at Scopus
  8. K. L. Moreau, A. J. Donato, D. R. Seals, C. A. DeSouza, and H. Tanaka, “Regular exercise, hormone replacement therapy and the age-related decline in carotid arterial compliance in healthy women,” Cardiovascular Research, vol. 57, no. 3, pp. 861–868, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. K. L. Moreau, B. L. Stauffer, W. M. Kohrt, and D. R. Seals, “Essential role of estrogen for improvements in vascular endothelial function with endurance exercise in postmenopausal women,” The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 1, pp. 4507–4515, 2013. View at Publisher · View at Google Scholar
  10. R. Rossi, A. Nuzzo, G. Origliani, and M. G. Modena, “Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women,” Journal of the American College of Cardiology, vol. 51, no. 10, pp. 997–1002, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. F. Furchgott and J. V. Zawadzki, “The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine,” Nature, vol. 288, no. 5789, pp. 373–376, 1980. View at Publisher · View at Google Scholar · View at Scopus
  12. D. S. Celermajer, K. E. Sorensen, D. J. Spiegelhalter, D. Georgakopoulos, J. Robinson, and J. E. Deanfield, “Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women,” Journal of the American College of Cardiology, vol. 24, no. 2, pp. 471–476, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Taddei, A. Virdis, L. Ghiadoni et al., “Menopause is associated with endothelial dysfunction in women,” Hypertension, vol. 28, no. 4, pp. 576–582, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. K. L. Moreau, K. D. Deane, A. L. Meditz, and W. M. Kohrt, “Tumor necrosis factor-a inhibition improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women,” Atherosclerosis, vol. 230, pp. 390–396, 2013. View at Google Scholar
  15. A. Sherwood, J. K. Bower, J. McFetridge-Durdle, J. A. Blumenthal, L. K. Newby, and A. L. Hinderliter, “Age moderates the short-term effects of transdermal 17β-estradiol on endothelium-dependent vascular function in postmenopausal women,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 8, pp. 1782–1787, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Vitale, G. Mercuro, E. Cerquetani et al., “Time since menopause influences the acute and chronic effect of estrogens on endothelial function,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 2, pp. 348–352, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. P. J. M. Best, P. B. Berger, V. M. Miller, and A. Lerman, “The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women,” Annals of Internal Medicine, vol. 128, no. 4, pp. 285–288, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Kawano, T. Motoyama, K. Kugiyama et al., “Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation,” Journal of the American College of Cardiology, vol. 30, no. 4, pp. 914–919, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. E. H. Lieberman, M. D. Gerhard, A. Uehata et al., “Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women,” Annals of Internal Medicine, vol. 121, no. 12, pp. 936–941, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Tan, M. V. Gurjar, R. V. Sharma, and R. C. Bhalla, “Estrogen receptor-α gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration,” Cardiovascular Research, vol. 43, no. 3, pp. 788–797, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. K. H. Kim, K. Moriarty, and J. R. Bender, “Vascular cell signaling by membrane estrogen receptors,” Steroids, vol. 73, no. 9-10, pp. 864–869, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. E. Mendelsohn and R. H. Karas, “HRT and the young at heart,” The New England Journal of Medicine, vol. 356, no. 25, pp. 2639–2641, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. G. M. Rubanyi, A. D. Freay, K. Kauser et al., “Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta: gender difference and effect of estrogen receptor gene disruption,” Journal of Clinical Investigation, vol. 99, no. 10, pp. 2429–2437, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Pinna, A. Cignarella, P. Sanvito, V. Pelosi, and C. Bolego, “Prolonged ovarian hormone deprivation impairs the protective vascular actions of estrogen receptor alpha agonists,” Hypertension, vol. 51, no. 4, pp. 1210–1217, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. J. Pinzone, H. Stevenson, J. S. Strobl, and P. E. Berg, “Molecular and cellular determinants of estrogen receptor α expression,” Molecular and Cellular Biology, vol. 24, no. 11, pp. 4605–4612, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. A. H. Wagner, M. R. Schroeter, and M. Hecker, “17β-estradiol inhibition of NADPH oxidase expression in human endothelial cells,” The FASEB Journal, vol. 15, no. 12, pp. 2121–2130, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Sudoh, K. Toba, M. Akishita et al., “Estrogen prevents oxidative stress-induced endothelial cell apoptosis in rats,” Circulation, vol. 103, no. 5, pp. 724–729, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. J. F. Keaney Jr., G. T. Shwaery, A. Xu et al., “17β-Estradiol preserves endothelial vasodilator function and limits low- density lipoprotein oxidation in hypercholesterolemic swine,” Circulation, vol. 89, no. 5, pp. 2251–2259, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Eskurza, K. D. Monahan, J. A. Robinson, and D. R. Seals, “Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing,” The Journal of Physiology, vol. 556, part 1, pp. 315–324, 2004. View at Google Scholar
  30. S. Taddei, A. Virdis, L. Ghiadoni et al., “Age-related reduction of NO availability and oxidative stress in humans,” Hypertension, vol. 38, no. 2, pp. 274–279, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. V. B. O'Donnell and B. A. Freeman, “Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease,” Circulation Research, vol. 88, no. 1, pp. 12–21, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Kojda and D. Harrison, “Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure,” Cardiovascular Research, vol. 43, no. 3, pp. 562–571, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. K. K. Lam, Y. M. Lee, G. Hsiao, S. Y. Chen, and M. H. Yen, “Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariectomized rats,” Menopause, vol. 13, no. 2, pp. 294–302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. C. F. H. Mueller, K. Laude, J. S. McNally, and D. G. Harrison, “Redox mechanisms in blood vessels,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 2, pp. 274–278, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Virdis, L. Ghiadoni, S. Pinto et al., “Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women,” Circulation, vol. 101, no. 19, pp. 2258–2263, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Wassmann, K. Wassmann, and G. Nickenig, “Modulation of oxidant and antioxidant enzyme expression and function in vascular cells,” Hypertension, vol. 44, no. 4, pp. 381–386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. N. J. Alp and K. M. Channon, “Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 3, pp. 413–420, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. M. J. Crabtree, A. L. Tatham, A. B. Hale, N. J. Alp, and K. M. Channon, “Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways,” Journal of Biological Chemistry, vol. 284, no. 41, pp. 28128–28136, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Lam, S. Ho, and M. Yen, “Tetrahydrobiopterin improves vascular endothelial function in ovariectomized rats,” Journal of Biomedical Science, vol. 9, no. 2, pp. 119–125, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. I. A. Arenas, S. J. Armstrong, Y. Xu, and S. T. Davidge, “Chronic tumor necrosis factor-α inhibition enhances NO modulation of vascular function in estrogen-deficient rats,” Hypertension, vol. 46, no. 1, pp. 76–81, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Csiszar, N. Labinskyy, K. Smith, A. Rivera, Z. Orosz, and Z. Ungvari, “Vasculoprotective effects of anti-tumor necrosis factor-α treatment in aging,” The American Journal of Pathology, vol. 170, no. 1, pp. 388–398, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. I. A. Arenas, S. J. Armstrong, Y. Xu, and S. T. Davidge, “Tumor necrosis factor-α and vascular angiotensin II in estrogen-deficient rats,” Hypertension, vol. 48, no. 3, pp. 497–503, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. G. J. Blake and P. M. Ridker, “Novel clinical markers of vascular wall inflammation,” Circulation Research, vol. 89, no. 9, pp. 763–771, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. M. E. Widlansky, N. Gokce, J. F. Keaney Jr., and J. A. Vita, “The clinical implications of endothelial dysfunction,” Journal of the American College of Cardiology, vol. 42, no. 7, pp. 1149–1160, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. B. R. Clapp, A. D. Hingorani, R. K. Kharbanda et al., “Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress,” Cardiovascular Research, vol. 64, no. 1, pp. 172–178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Pleiner, F. Mittermayer, G. Schaller, C. Marsik, R. J. MacAllister, and M. Wolzt, “Inflammation-induced vasoconstrictor hyporeactivity is caused by oxidative stress,” Journal of the American College of Cardiology, vol. 42, no. 9, pp. 1656–1662, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Yoshizumi, M. A. Perrella, J. C. Burnett Jr., and M.-E. Lee, “Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life,” Circulation Research, vol. 73, no. 1, pp. 205–209, 1993. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Mittermayer, J. Pleiner, G. Schaller et al., “Tetrahydrobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction,” The American Journal of Physiology: Heart and Circulatory Physiology, vol. 289, no. 4, pp. H1752–H1757, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. L. A. Madge and J. S. Pober, “TNF signaling in vascular endothelial cells,” Experimental and Molecular Pathology, vol. 70, no. 3, pp. 317–325, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Abu-Taha, C. Rius, C. Hermenegildo et al., “Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan,” Journal of Immunology, vol. 183, no. 2, pp. 1393–1402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Bismar, I. Diel, R. Ziegler, and J. Pfeilschifter, “Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement,” The Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 11, pp. 3351–3355, 1995. View at Google Scholar · View at Scopus
  52. S. Vehkavaara, A. Silveira, T. Hakala-Ala-Pietilä et al., “Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women,” Thrombosis and Haemostasis, vol. 85, no. 4, pp. 619–625, 2001. View at Google Scholar · View at Scopus
  53. L. Sunday, M. M. Tran, D. N. Krause, and S. P. Duckles, “Estrogen and progestagens differentially modulate vascular proinflammatory factors,” The American Journal of Physiology: Endocrinology and Metabolism, vol. 291, no. 2, pp. E261–E267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Sumino, S. Ichikawa, S. Kasama et al., “Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women,” Atherosclerosis, vol. 189, no. 2, pp. 436–442, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Xing, W. Feng, A. P. Miller et al., “Estrogen modulates TNF-α-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-β activation,” The American Journal of Physiology: Heart and Circulatory Physiology, vol. 292, no. 6, pp. H2607–H2612, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. N. G. Majmudar, S. C. Robson, and G. A. Ford, “Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 4, pp. 1577–1583, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. D. K. Arnett, G. W. Evans, and W. A. Riley, “Arterial stiffness: a new cardiovascular risk factor?” The American Journal of Epidemiology, vol. 140, no. 8, pp. 669–682, 1994. View at Google Scholar · View at Scopus
  58. M. O'Rourke, “Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension,” Hypertension, vol. 15, no. 4, pp. 339–347, 1990. View at Publisher · View at Google Scholar · View at Scopus
  59. M. O'Rourke, “Mechanical principles in arterial disease,” Hypertension, vol. 26, no. 1, pp. 2–9, 1995. View at Publisher · View at Google Scholar · View at Scopus
  60. R. B. Rucker and D. Tinker, “Structure and metabolism of arterial elastin,” International Review of Experimental Pathology, vol. 17, pp. 1–47, 1977. View at Google Scholar · View at Scopus
  61. H. Smulyan, R. G. Asmar, A. Rudnicki, G. M. London, and M. E. Safar, “Comparative effects of aging in men and women on the properties of the arterial tree,” Journal of the American College of Cardiology, vol. 37, pp. 1374–1380, 2001. View at Google Scholar
  62. Y. Nagai, C. J. Earley, M. K. Kemper, C. S. Bacal, and E. J. Metter, “Influence of age and postmenopausal estrogen replacement therapy on 1 carotid arterial stiffness in women,” Cardiovascular Research, vol. 41, no. 1, pp. 307–311, 1999. View at Publisher · View at Google Scholar · View at Scopus
  63. I. C. D. Westendorp, M. L. Bots, D. E. Grobbee et al., “Menopausal status and distensibility of the common carotid artery,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 3, pp. 713–717, 1999. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Rajkumar, B. A. Kingwell, J. D. Cameron et al., “Hormonal therapy increases arterial compliance in postmenopausal women,” Journal of the American College of Cardiology, vol. 30, no. 2, pp. 350–356, 1997. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Scuteri, E. G. Lakatta, A. J. G. Bos, and J. L. Fleg, “Effect of estrogen and progestin replacement on arterial stiffness indices in postmenopausal women,” Aging—Clinical and Experimental Research, vol. 13, no. 2, pp. 122–130, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. L. Liang, H. Teede, and L. M. Shiell, “Effects of oestrogen and progesterone on age-related changes in arteries of postmenopausal women,” Clinical and Experimental Pharmacology and Physiology, vol. 24, no. 6, pp. 457–459, 1997. View at Google Scholar · View at Scopus
  67. A. K. Natoli, T. L. Medley, A. A. Ahimastos et al., “Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression,” Hypertension, vol. 46, no. 5, pp. 1129–1134, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. W. A. Riley, G. W. Evans, A. R. Sharrett, G. L. Burke, and R. W. Barnes, “Variation of common carotid artery elasticity with intimal-medial thickness: the ARIC study,” Ultrasound in Medicine and Biology, vol. 23, no. 2, pp. 157–164, 1997. View at Publisher · View at Google Scholar · View at Scopus
  69. R. K. Dubey, E. K. Jackson, D. G. Gillespie, L. C. Zacharia, B. Imthurn, and P. J. Keller, “Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 4, pp. 964–972, 2000. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Matsuda, T. Nosaka, M. Sato, and N. Ohshima, “Effects of physical exercise on the elasticity and elastic components of the rat aorta,” European Journal of Applied Physiology and Occupational Physiology, vol. 66, no. 2, pp. 122–126, 1993. View at Publisher · View at Google Scholar · View at Scopus
  71. B. K. Yoon, W. K. Oh, B. Kessel et al., “17β-estradiol inhibits proliferation of cultured vascular smooth muscle cells induced by lysophosphatidylcholine via a nongenomic antioxidant mechanism,” Menopause, vol. 8, no. 1, pp. 58–64, 2001. View at Publisher · View at Google Scholar · View at Scopus
  72. R. K. Dubey, D. G. Gillespie, L. C. Zacharia et al., “Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms,” Biochemical and Biophysical Research Communications, vol. 278, no. 1, pp. 27–33, 2000. View at Publisher · View at Google Scholar · View at Scopus
  73. M. A. Espeland, W. Applegate, C. D. Furberg, D. Lefkowitz, L. Rice, and D. Hunninghake, “Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women,” The American Journal of Epidemiology, vol. 142, no. 10, pp. 1011–1019, 1995. View at Google Scholar · View at Scopus
  74. B. P. McGrath, Y. Liang, H. Teede, L. M. Shiel, J. D. Cameron, and A. Dart, “Age-related deterioration in arterial structure and function in postmenopausal women: Impact of hormone replacement therapy,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 7, pp. 1149–1156, 1998. View at Publisher · View at Google Scholar · View at Scopus
  75. F. A. Tremollieres, F. Cigagna, C. Alquier, C. Cauneille, J. Pouilles, and C. Ribot, “Effect of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women,” Atherosclerosis, vol. 153, no. 1, pp. 81–88, 2000. View at Publisher · View at Google Scholar · View at Scopus
  76. I. C. D. Westendorp, B. A. In't Veld, M. L. Bots et al., “Hormone replacement therapy and intima-media thickness of the common carotid artery: the Rotterdam study,” Stroke, vol. 30, no. 12, pp. 2562–2567, 1999. View at Publisher · View at Google Scholar · View at Scopus
  77. I. B. Wilkinson, A. Qasem, C. M. McEniery, D. J. Webb, A. P. Avolio, and J. R. Cockcroft, “Nitric oxide regulates local arterial distensibility in vivo,” Circulation, vol. 105, no. 2, pp. 213–217, 2002. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Sugawara, H. Komine, K. Hayashi et al., “Effect of systemic nitric oxide synthase inhibition on arterial stiffness in humans,” Hypertension Research, vol. 30, no. 5, pp. 411–415, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. R. P. Wildman, A. B. Colvin, L. H. Powell et al., “Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN),” Menopause, vol. 15, no. 3, pp. 414–421, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. K. A. Matthews, L. H. Kuller, K. Sutton-Tyrrell, and Y. Chang, “Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women,” Stroke, vol. 32, no. 5, pp. 1104–1110, 2001. View at Publisher · View at Google Scholar · View at Scopus
  81. C. Vassalle, L. Petrozzi, N. Botto, M. G. Andreassi, and G. C. Zucchelli, “Oxidative stress and its association with coronary artery disease and different atherogenic risk factors,” Journal of Internal Medicine, vol. 256, no. 4, pp. 308–315, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. N. Kuzkaya, N. Weissmann, D. G. Harrison, and S. Dikalov, “Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase,” The Journal of Biological Chemistry, vol. 278, no. 25, pp. 22546–22554, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. A. D. Booth, S. Wallace, C. M. McEniery, J. Brown, D. R. W. Jayne, and I. B. Wilkinson, “Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation,” Arthritis and Rheumatism, vol. 50, no. 2, pp. 581–588, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. K. M. Mäki-Petäjä, F. C. Hall, A. D. Booth et al., “Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-α therapy,” Circulation, vol. 114, no. 11, pp. 1185–1192, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. G. A. Woodard, V. G. Mehta, R. H. MacKey et al., “C-reactive protein is associated with aortic stiffness in a cohort of African American and white women transitioning through menopause,” Menopause, vol. 18, no. 12, pp. 1291–1297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. J. E. Manson, P. Greenland, A. Z. LaCroix et al., “Walking compared with vigorous exercise for the prevention of cardiovascular events in women,” The New England Journal of Medicine, vol. 347, no. 10, pp. 716–725, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Mora, N. Cook, J. E. Buring, P. M. Ridker, and I.-M. Lee, “Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms,” Circulation, vol. 116, no. 19, pp. 2110–2118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. S. S. Najjar, A. Scuteri, and E. G. Lakatta, “Arterial aging: is it an immutable cardiovascular risk factor?” Hypertension, vol. 46, no. 3, pp. 454–462, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. H. Tanaka, C. A. DeSouza, and D. R. Seals, “Absence of age-related increase in central arterial stiffness in physically active women,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 1, pp. 127–132, 1998. View at Publisher · View at Google Scholar · View at Scopus
  90. K. L. Moreau, K. M. Gavin, A. E. Plum, and D. R. Seals, “Oxidative stress explains differences in large elastic artery compliance between sedentary and habitually exercising postmenopausal women,” Menopause, vol. 13, no. 6, pp. 951–958, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. T. Matsubara, A. Miyaki, N. Akazawa et al., “Aerobic exercise training increases plasma Klotho levels and reduces arterial stiffness in postmenopausal women,” The American Journal of Physiology: Heart and Circulatory Physiology, vol. 306, no. 3, pp. H348–H355, 2014. View at Publisher · View at Google Scholar
  92. K. Tanahashi, N. Akazawa, A. Miyaki et al., “Aerobic exercise training decreases plasma asymmetric dimethylarginine concentrations with increase in arterial compliance in postmenopausal women,” The American Journal of Hypertension, vol. 27, no. 3, pp. 415–421, 2014. View at Publisher · View at Google Scholar
  93. J. Sugawara, H. Inoue, K. Hayashi, T. Yokoi, and I. Kono, “Effect of low-intensity aerobic exercise training on arterial compliance in postmenopausal women,” Hypertension Research, vol. 27, no. 12, pp. 897–901, 2004. View at Publisher · View at Google Scholar · View at Scopus
  94. I. Eskurza, L. A. Myerburgh, Z. D. Kahn, and D. R. Seals, “Tetrahydrobiopterin augments endothelium-dependent dilatation in sedentary but not in habitually exercising older adults,” The Journal of Physiology, vol. 568, no. 3, pp. 1057–1065, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. C. A. DeSouza, L. F. Shapiro, C. M. Clevenger et al., “Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men,” Circulation, vol. 102, no. 12, pp. 1351–1357, 2000. View at Publisher · View at Google Scholar · View at Scopus
  96. F. Franzoni, L. Ghiadoni, F. Galetta et al., “Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men,” The American Journal of Hypertension, vol. 18, no. 4, pp. 510–516, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. M. R. Rinder, R. J. Spina, and A. A. Ehsani, “Enhanced endothelium-dependent vasodilation in older endurance-trained men,” Journal of Applied Physiology, vol. 88, no. 2, pp. 761–766, 2000. View at Google Scholar · View at Scopus
  98. T. M. Rywik, M. R. Blackman, A. R. Yataco et al., “Enhanced endothelial vasoreactivity in endurance-trained older men,” Journal of Applied Physiology, vol. 87, no. 6, pp. 2136–2142, 1999. View at Google Scholar · View at Scopus
  99. G. L. Pierce, I. Eskurza, A. E. Walker, T. N. Fay, and D. R. Seals, “Sex-specific effects of habitual aerobic exercise on brachial artery flow-mediated dilation in middle-aged and older adults,” Clinical Science, vol. 120, no. 1, pp. 13–23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. D. P. Casey, G. L. Pierce, K. S. Howe, M. C. Mering, and R. W. Braith, “Effect of resistance training on arterial wave reflection and brachial artery reactivity in normotensive postmenopausal women,” European Journal of Applied Physiology, vol. 100, no. 4, pp. 403–408, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. B. A. Parker, M. J. Kalasky, and D. N. Proctor, “Evidence for sex differences in cardiovascular aging and adaptive responses to physical activity,” European Journal of Applied Physiology, vol. 110, no. 2, pp. 235–246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. R. Lew, P. Komesaroff, M. Williams, T. Dawood, and K. Sudhir, “Endogenous estrogens influence endothelial function in young men,” Circulation Research, vol. 93, no. 11, pp. 1127–1133, 2003. View at Publisher · View at Google Scholar · View at Scopus
  103. P. J. L. Ong, G. Patrizi, W. C. F. Chong, C. M. Webb, C. S. Hayward, and P. Collins, “Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease,” The American Journal of Cardiology, vol. 85, no. 2, pp. 269–272, 2000. View at Publisher · View at Google Scholar · View at Scopus
  104. M. Tanasescu, M. F. Leitzmann, E. B. Rimm, W. C. Willett, M. J. Stampfer, and F. B. Hu, “Exercise type and intensity in relation to coronary heart disease in men,” Journal of the American Medical Association, vol. 288, no. 16, pp. 1994–2000, 2002. View at Publisher · View at Google Scholar · View at Scopus
  105. A. K. Chomistek, N. R. Cook, A. J. Flint, and E. B. Rimm, “Vigorous-intensity leisure-time physical activity and risk of major chronic disease in men,” Medicine and Science in Sports and Exercise, vol. 44, no. 10, pp. 1898–1905, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. C. A. D. Silva, J. P. Ribeiro, J. C. A. U. Canto et al., “High-intensity aerobic training improves endothelium-dependent vasodilation in patients with metabolic syndrome and type 2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 95, no. 2, pp. 237–245, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. K. D. Currie, R. S. McKelvie, and M. J. MacDonald, “Flow-mediated dilation is acutely improved after high-intensity interval exercise,” Medicine and Science in Sports and Exercise, vol. 44, no. 11, pp. 2057–2064, 2012. View at Publisher · View at Google Scholar · View at Scopus
  108. D. L. Swift, J. Y. Weltman, J. T. Patrie et al., “Predictors of improvement in endothelial function after exercise training in a diverse sample of postmenopausal women,” Journal of Women's Health (Larchmt), vol. 23, no. 3, pp. 260–266, 2014. View at Google Scholar
  109. N. Yoshida, H. Ikeda, K. Sugi, and T. Imaizumi, “Impaired endothelium-dependent and -independent vasodilation in young female athletes with exercise-associated amenorrhea,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 1, pp. 231–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  110. A. Rickenlund, M. J. Eriksson, K. Schenck-Gustafsson, and A. L. Hirschberg, “Oral contraceptives improve endothelial function in amenorrheic athletes,” The Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 6, pp. 3162–3167, 2005. View at Publisher · View at Google Scholar · View at Scopus
  111. L. Mosca, L. J. Appel, E. J. Benjamin et al., “Evidence-based guidelines for cardiovascular disease prevention in women,” Circulation, vol. 109, no. 5, pp. 672–693, 2004. View at Publisher · View at Google Scholar · View at Scopus
  112. F. S. Gragasin, Y. Xu, I. A. Arenas, N. Kainth, and S. T. Davidge, “Estrogen reduces angiotensin II-induced nitric oxide synthase and NADPH oxidase expression in endothelial cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 1, pp. 38–44, 2003. View at Publisher · View at Google Scholar · View at Scopus